Hall I H, Morse K W, Spielvogel B F, Sood A
Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina, Chapel Hill 27599-7360.
Anticancer Drugs. 1991 Aug;2(4):389-99. doi: 10.1097/00001813-199108000-00009.
A series of metal complexes and sodium salts of substituted boranes and hydroborates was shown to have cytotoxicity in murine and human tumor screens. Most of these agents were active against the growth of L-1210, Tmolt3 and Hela-S3. Selected agents demonstrated activity against the growth of monolayer human cell lines derived from solid tumors. Interestingly, many of the compounds demonstrated even lower ED50 values in the solid tumor than the L-1210 leukemic screen. Four compounds, Cu2(m-CH3)3NBH2CO2)4.2(CH3)NBH2COOH (I), [Fe3O((CH3)3NBH2CO2)6(CH3OH)3]NO3.CH3CN (II), cis-[Co(en)2((CH3)3N.BH2CO2)2]Cl.2.5 H2O.0.5 CH3OH (V), and Na(CH3)3NBH2CO2.0.25 CH3OH (IX) were shown preferentially to inhibit DNA synthesis of L-1210 cells with only moderate inhibition of RNA and protein synthesis. In preliminary studies these agents effectively inhibited the activities of regulatory enzymes involved in the purine pathway and nucleoside kinases resulting in the suppression of d(NTP) pool levels. The boron derivatives also caused L-1210 DNA strand scission. These drugs may act together to inhibit DNA synthesis and induce cytotoxicity.
一系列金属配合物以及取代硼烷和硼氢化物的钠盐在小鼠和人类肿瘤筛查中显示出细胞毒性。这些药物大多数对L-1210、Tmolt3和Hela-S3的生长具有活性。选定的药物对源自实体瘤的单层人类细胞系的生长显示出活性。有趣的是,许多化合物在实体瘤中的ED50值甚至比L-1210白血病筛查中的还要低。四种化合物,即Cu2(m-CH3)3NBH2CO2)4.2(CH3)NBH2COOH(I)、[Fe3O((CH3)3NBH2CO2)6(CH3OH)3]NO3.CH3CN(II)、顺式-[Co(en)2((CH3)3N.BH2CO2)2]Cl.2.5 H2O.0.5 CH3OH(V)和Na(CH3)3NBH2CO2.0.25 CH3OH(IX)被证明优先抑制L-1210细胞的DNA合成,而对RNA和蛋白质合成只有中度抑制。在初步研究中,这些药物有效地抑制了嘌呤途径和核苷激酶中涉及的调节酶的活性,导致d(NTP)池水平的抑制。硼衍生物还导致L-1210 DNA链断裂。这些药物可能共同作用以抑制DNA合成并诱导细胞毒性。